Induced pluripotent stem cell technology for dissecting the cancer epigenome
about
An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development10th anniversary of iPS cells: the challenges that lie ahead.Current status in cancer cell reprogramming and its clinical implications.Cellular reprogramming technology for dissecting cancer epigenome in vivo.
P2860
Induced pluripotent stem cell technology for dissecting the cancer epigenome
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@ast
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@en
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@nl
type
label
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@ast
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@en
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@nl
prefLabel
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@ast
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@en
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@nl
P2860
P921
P356
P1433
P1476
Induced pluripotent stem cell technology for dissecting the cancer epigenome
@en
P2093
Katsunori Semi
Yasuhiro Yamada
P2860
P304
P356
10.1111/CAS.12758
P407
P5008
P577
2015-10-01T00:00:00Z